85 research outputs found
Programmable DARPin-based receptors for the detection of thrombotic markers
Cellular therapies remain constrained by the limited availability of sensors for disease markers. Here we present an integrated target-to-receptor pipeline for constructing a customizable advanced modular bispecific extracellular receptor (AMBER) that combines our generalized extracellular molecule sensor (GEMS) system with a high-throughput platform for generating designed ankyrin repeat proteins (DARPins). For proof of concept, we chose human fibrin degradation products (FDPs) as markers with high clinical relevance and screened a DARPin library for FDP binders. We built AMBERs equipped with 19 different DARPins selected from 160 hits, and found 4 of them to be functional as heterodimers with a known single-chain variable fragments binder. Tandem receptors consisting of combinations of the validated DARPins are also functional. We demonstrate applications of these AMBER receptors in vitro and in vivo by constructing designer cell lines that detect pathological concentrations of FDPs and respond with the production of a reporter and a therapeutic anti-thrombotic protein
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.
The V3 loop of the HIV-1 envelope (Env) protein elicits a vigorous, but largely non-neutralizing antibody response directed to the V3-crown, whereas rare broadly neutralizing antibodies (bnAbs) target the V3-base. Challenging this view, we present V3-crown directed broadly neutralizing Designed Ankyrin Repeat Proteins (bnDs) matching the breadth of V3-base bnAbs. While most bnAbs target prefusion Env, V3-crown bnDs bind open Env conformations triggered by CD4 engagement. BnDs achieve breadth by focusing on highly conserved residues that are accessible in two distinct V3 conformations, one of which resembles CCR5-bound V3. We further show that these V3-crown conformations can, in principle, be attacked by antibodies. Supporting this conclusion, analysis of antibody binding activity in the Swiss 4.5 K HIV-1 cohort (n = 4,281) revealed a co-evolution of V3-crown reactivities and neutralization breadth. Our results indicate a role of V3-crown responses and its conformational preferences in bnAb development to be considered in preventive and therapeutic approaches
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization
The third variable (V3) loop on the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein trimer is indispensable for virus cell entry. Conformational masking of V3 within the trimer allows efficient neutralization via V3 only by rare, broadly neutralizing glycan-dependent antibodies targeting the closed prefusion trimer but not by abundant antibodies that access the V3 crown on open trimers after CD4 attachment. Here, we report on a distinct category of V3-specific inhibitors based on designed ankyrin repeat protein (DARPin) technology that reinstitute the CD4-bound state as a key neutralization target with up to >90% breadth. Broadly neutralizing DARPins (bnDs) bound V3 solely on open envelope and recognized a four-turn amphipathic α-helix in the carboxy-terminal half of V3 (amino acids 314-324), which we termed 'αV3C'. The bnD contact surface on αV3C was as conserved as the CD4 binding site. Molecular dynamics and escape mutation analyses underscored the functional relevance of αV3C, highlighting the potential of αV3C-based inhibitors and, more generally, of postattachment inhibition of HIV-1
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73
Dysregulation of cellular transcription and translation is a fundamental hallmark
of cancer. As CDK9 and Mnks play pivotal roles in the regulation of RNA transcription
and protein synthesis, respectively, they are important targets for drug development.
We herein report the cellular mechanism of a novel CDK9 inhibitor CDKI-73 in an
ovarian cancer cell line (A2780). We also used shRNA-mediated CDK9 knockdown
to investigate the importance of CDK9 in the maintenance of A2780 cells. This study
revealed that CDKI-73 rapidly inhibited cellular CDK9 kinase activity and downregulated
the RNAPII phosphorylation. This subsequently caused a decrease in the
eIF4E phosphorylation by blocking Mnk1 kinase activity. Consistently, CDK9 shRNA
was also found to down-regulate the Mnk1 expression. Both CDKI-73 and CDK9 shRNA
decreased anti-apoptotic proteins Mcl-1 and Bcl-2 and induced apoptosis. The study
confirmed that CDK9 is required for cell survival and that ovarian cancer may be
susceptible to CDK9 inhibition strategy. The data also implied a role of CDK9 in eIF4Emediated
translational control, suggesting that CDK9 may have important implication
in the Mnk-eIF4E axis, the key determinants of PI3K/Akt/mTOR- and Ras/Raf/MAPKmediated
tumorigenic activity. As such, CDK9 inhibitor drug candidate CDKI-73 should
have a major impact on these pathways in human cancers
Assessing immunogenicity barriers of the HIV-1 envelope trimer
Understanding the balance between epitope shielding and accessibility on HIV-1 envelope (Env) trimers is essential to guide immunogen selection for broadly neutralizing antibody (bnAb) based vaccines. To investigate the antigenic space of Env immunogens, we created a strategy based on synthetic, high diversity, Designed Ankyrin Repeat Protein (DARPin) libraries. We show that DARPin Antigenicity Analysis (DANA), a purely in vitro screening tool, has the capability to extrapolate relevant information of antigenic properties of Env immunogens. DANA screens of stabilized, soluble Env trimers revealed that stronger trimer stabilization led to the selection of highly mutated DARPins with length variations and framework mutations mirroring observations made for bnAbs. By mimicking heterotypic prime-boost immunization regimens, DANA may be used to select immunogen combinations that favor the selection of trimer-reactive binders. This positions DANA as a versatile strategy for distilling fundamental antigenic features of immunogens, complementary to preclinical immunogenicity testing
Aggregate Unemployment Decreases Individual Returns to Education
On the basis of a theoretical model, we argue that higher aggregate unemployment affects individual returns to education. We therefore include aggregate unemployment and an interaction term between unemployment and the individual education level in a standard Mincer equation. Our results show that an increase in regional unemployment by 1% decreases the returns to education by 0.005 percentage points. This implies that higher skilled employees are better sheltered from labour market changes with respect to their jobs but encounter larger wage changes than less skilled employees. Differences in regional unemployment can in addition almost fully explain the observed large differences in regional returns to education. We use representative individual data and regional panel variation in unemployment between different German regions and for different employee groups. We demonstrate that our results are robust with respect to aggregation bias, time lags and potential endogeneity of the unemployment variable
Recommended from our members
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.
Human Enhancer of Zeste homolog (Ezh2) is a histone lysine methyltransferase (HKMT) associated with transcriptional repression. Ezh2 is present in several distinct complexes, one of which, PRC2, we characterized previously. Here we report an additional Ezh2 complex, PRC3. We show that the Ezh2 complexes exhibit differential targeting of specific histones for lysine methylation dependent upon the context of the histone substrates. This differential targeting is a function of the associated Eed protein within each complex. We found that Eed protein is present in four isoforms, which represent alternate translation start site usage from the same mRNA. These Eed isoforms selectively associate with distinct Ezh2-containing complexes with resultant differential targeting of their associated HKMT activity toward histone H3-K27 or histone H1-K26. Our data provide evidence for a novel mechanism regulating the substrate specificity of a chromatin-modifying enzyme through disparate translational products of a regulatory subunit
A DARPin promotes faster onset of botulinum neurotoxin A1 action
In this study, we characterize Designed Ankyrin Repeat Proteins (DARPins) as investigative tools to probe botulinum neurotoxin A1 (BoNT/A1) structure and function. We identify DARPin-F5 that completely blocks SNAP25 substrate cleavage by BoNT/A1 in vitro. X-ray crystallography reveals that DARPin-F5 inhibits BoNT/A1 activity by interacting with a substrate-binding region between the α- and β-exosite. This DARPin does not block substrate cleavage of BoNT/A3, indicating that DARPin-F5 is a subtype-specific inhibitor. BoNT/A1 Glu-171 plays a critical role in the interaction with DARPin-F5 and its mutation to Asp, the residue found in BoNT/A3, results in a loss of inhibition of substrate cleavage. In contrast to the in vitro results, DARPin-F5 promotes faster substrate cleavage of BoNT/A1 in primary neurons and muscle tissue by increasing toxin translocation. Our findings could have important implications for the application of BoNT/A1 in therapeutic areas requiring faster onset of toxin action combined with long persistence
Recommended from our members
Analysis of the phiX174 gene A protein using in vitro DNA replication systems.
Publisher Summary The A gene of icosahedral single-stranded DNA phages encodes a protein that is required in vivo for duplex replicative form (RF) and single-stranded circular [SS(c)] viral DNA synthesis. The gene 2 protein of the filamentous single-strand DNA phages has an analogous function, both in vivo and in vitro , during phage RF and viral DNA synthesis. Indeed, the gene A protein of icosahedral phage such as ϕ X174 may be prototypic of a variety of endonucleases in nature, associated with several aspects of DNA synthesis and metabolism including recombination and transposition. The advent of recombinant DNA technology and the development of ϕ X174-specific in vitro DNA replication systems have given rise to a powerful methodology for the study of proteins such as the gene A protein. Methods developed for the analysis of multiple activities associated with the ϕ X A protein during DNA synthesis are described in this chapter. The systems described here have additional applications. ϕ X A protein-directed leading strand DNA synthesis in vitro , from recombinant plasmid templates, is used as a probe for studying mechanisms of initiation of lagging strand DNA replication. In addition, in vitro systems similar to those described have immediate applications in the analysis of molecular mechanisms of transposition
- …